Therefore, these data suggest that serum S100 proteins, such as S100A8/A9 and S100A12, are good biomarkers for the differential diagnosis of systemic JIA and AOSD, and for the evaluation of disease activity. This evidence concerns the gene S100A12 and adult-onset Still disease.